Recce Pharmaceuticals (ASX:RCE) Secures China Patent for Anti-Infectives
Recce Pharmaceuticals (ASX:RCE) secures a China Patent for its RECCE® anti-infectives, enhancing its global intellectual property portfolio.
Recce Pharmaceuticals (ASX:RCE) secures a China Patent for its RECCE® anti-infectives, enhancing its global intellectual property portfolio.
New Age Exploration (ASX:NAE) announces substantial RC drill results at Wagyu Project, indicating a promising supergene gold system.
OncoSil Medical (ASX:OSL) secures $8.7 million in capital to advance commercialisation and support ongoing clinical trials.
BSP Financial Group Limited (ASX:BFL) announces strong 2024 financial results with a 16% dividend increase and ongoing modernization initiatives.
Fortescue Ltd (ASX:FMG) announces a leadership update, including new CEO Growth and Energy, expanded roles, and the retirement of key executives.
Aston Minerals (ASX:ASO) and Torque Metals (ASX:TOR) receive shareholder approval for their merger, pending court confirmation.
Rio Tinto (ASX:RIO) reveals CEO succession plan, outlining leadership transition and continued strategic growth.
Restaurant Brands New Zealand Limited (ASX:RBD) reports record FY24 sales, improved margins, and declares a special dividend for shareholders.
Great Boulder Resources (ASX:GBR) confirms new gold discovery at Side Well South and extends Eaglehawk deposit by 200m, enhancing its exploration portfolio.
Sietel Limited (ASX:SSL) reports an 11% revenue decline and a 49% profit drop for the half-year ended 31 March 2025.